These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24250442)

  • 21. Situation analysis of R & d activities: an empirical study in Iranian pharmaceutical companies.
    Rasekh HR; Mehralian G; Vatankhah-Mohammadabadi AA
    Iran J Pharm Res; 2012; 11(4):1013-25. PubMed ID: 24250532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An optimized multi-attribute decision-making approach to construction supply chain management by using complex picture fuzzy soft set.
    Asghar A; Khan KA; Albahar MA; Alammari A
    PeerJ Comput Sci; 2023; 9():e1540. PubMed ID: 37705663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Financial aspects and the future of the pharmaceutical industry in the United States of america.
    Karamehic J; Ridic O; Ridic G; Jukic T; Coric J; Subasic D; Panjeta M; Saban A; Zunic L; Masic I
    Mater Sociomed; 2013 Dec; 25(4):286-90. PubMed ID: 24511277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supplier selection in the industry 4.0 era by using a fuzzy cognitive map and hesitant fuzzy linguistic VIKOR methodology.
    Hosseini Dolatabad A; Heidary Dahooie J; Antucheviciene J; Azari M; Razavi Hajiagha SH
    Environ Sci Pollut Res Int; 2023 Apr; 30(18):52923-52942. PubMed ID: 36843168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A supply risk perspective integrated sustainable supplier selection model in the intuitionistic fuzzy environment.
    Wu C; Zou H; Barnes D
    Soft comput; 2023 May; ():1-19. PubMed ID: 37362292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interorganizational cooperation and supplier performance in high-technology supply chains.
    Connor NO; Lowry PB; Treiblmaier H
    Heliyon; 2020 Mar; 6(3):e03434. PubMed ID: 32211539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Green supplier selection for textile industry: a case study using BWM-TODIM integration under interval type-2 fuzzy sets.
    Celik E; Yucesan M; Gul M
    Environ Sci Pollut Res Int; 2021 Dec; 28(45):64793-64817. PubMed ID: 34313933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A causality analysis of risks to perishable product supply chain networks during the COVID-19 outbreak era: An extended DEMATEL method under Pythagorean fuzzy environment.
    Shafiee M; Zare-Mehrjerdi Y; Govindan K; Dastgoshade S
    Transp Res E Logist Transp Rev; 2022 Jul; 163():102759. PubMed ID: 35637683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021.
    Wande DP; Sangeda RZ; Tibalinda P; Mutta IK; Mkumbwa S; Bitegeko A; Kaale E
    PLoS One; 2019; 14(8):e0220701. PubMed ID: 31404109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing a Risk Reduction Support System for Health System in Iran: A Case Study in Blood Supply Chain Management.
    Sibevei A; Azar A; Zandieh M; Khalili SM; Yazdani M
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presenting an agile supply chain mathematical model for COVID-19 (Corona) drugs using metaheuristic algorithms (case study: pharmaceutical industry).
    Shayannia SA
    Environ Sci Pollut Res Int; 2023 Jan; 30(3):6559-6572. PubMed ID: 35999421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data driven flexible supplier network of selfcare essentials during disruptions in supply chain.
    Chauhan A; Kaur H; Mangla SK; Kayikci Y
    Ann Oper Res; 2023 Apr; ():1-31. PubMed ID: 37361072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Of barriers and bridges: Buyer-supplier relationships in health care.
    Abdulsalam YJ; Schneller ES
    Health Care Manage Rev; 2021 Oct-Dec 01; 46(4):358-366. PubMed ID: 32167964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustainable circular supplier selection: A novel hybrid approach.
    Kannan D; Mina H; Nosrati-Abarghooee S; Khosrojerdi G
    Sci Total Environ; 2020 Jun; 722():137936. PubMed ID: 32213433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supply chain vulnerability assessment for manufacturing industry.
    Sharma SK; Srivastava PR; Kumar A; Jindal A; Gupta S
    Ann Oper Res; 2021 Jun; ():1-31. PubMed ID: 34149141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study on sustainable development of pharmaceutical health industry under ecological coordination.
    Fu G; Zhao Z
    Front Public Health; 2023; 11():1117701. PubMed ID: 36844849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supply chain resilience vs. COVID-19 disruptions during the second wave.
    Lahyani R; AlSaad F; Merdad L; Alzamel M
    Procedia CIRP; 2021; 103():42-48. PubMed ID: 34692396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.